Key result
Direct unilateral image-guided focused ultrasound ablation of the carotid body significantly reduced mean arterial pressure in spontaneously hypertensive rats compared to sham treatment (p=0.0004).
Why the study?
Enhanced carotid body activity correlates with elevated blood pressure in hypertension, and prior removal or denervation reduced hypertension, prompting evaluation of noninvasive ultrasound ablation.
Does image-guided focused ultrasound ablation of the carotid body reduce mean arterial pressure in spontaneously hypertensive rats?
Does image-guided focused ultrasound ablation of the carotid body reduce mean arterial pressure in spontaneously hypertensive rats?
Non-invasive, image-guided focused ultrasound ablation of the carotid body is feasible and effectively reduces blood pressure in a hypertensive rat model, suggesting potential as a device-based therapy for hypertension.
Carotid bodies (CBs) are chemoreceptors that monitor and register changes in the blood, including the levels of oxygen, carbon dioxide, and pH, and regulate breathing. Enhanced activity of CBs was shown to correlate with a significant elevation in the blood pressure of patients with hypertension. CB removal or denervation were previously shown to reduce hypertension. Here we demonstrate the feasibility of a dual-mode ultrasound array (DMUA) system to safely ablate the CB in vivo in a spontaneously hypertensive rat (SHR) model of hypertension. DMUA imaging was used for guiding and monitoring focused ultrasound (FUS) energy delivered to the target region. In particular, 3D imaging was used to identify the carotid bifurcation for targeting the CBs. Intermittent, high frame rate imaging during image-guided FUS (IgFUS) delivery was used for monitoring the lesion formation. DMUA imaging provided feedback for closed-loop control (CLC) of the lesion formation process to avoid overexposure. The procedure was tolerated well in over 100 SHR and normotensive rats that received unilateral and bilateral treatments. The measured mean arterial pressure (MAP) exhibited measurable deviation from baseline 2-4 weeks post IgFUS treatment. The results suggest that the direct unilateral FUS treatment of the CB might be sufficient to reduce the blood pressure in hypertensive rats and justify further investigation in large animals and eventually in human patients.
No takes yet. Share an insight, caveat, or question.
Aravalli et al. (2020) studied Hypertension (n=100). Image-guided focused ultrasound (IgFUS) ablation vs. Sham treatment was evaluated on Mean arterial pressure (MAP) (p=0.0004). Direct unilateral image-guided focused ultrasound ablation of the carotid body significantly reduced mean arterial pressure in spontaneously hypertensive rats compared to sham treatment (p=0.0004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: